Skip to content
Case Study

Medical Device Supply Chain Visibility & Risk Management

From Partial Visibility to Full Multi-Tier Supply Chain Control

Mapped multi-tier supplier networks with 100% validated tier 2 accuracy uncovering hidden dependencies and enabling faster, data-driven sourcing decisions.

 

Client Challenge

A global medical device manufacturer needed deeper visibility into its supply chain to maintain supply certainty, manage risk, and meet strict regulatory requirements.

med-tech-1

Despite having established processes and strong supplier relationships, visibility was largely limited to tier 1, creating exposure to:

  • Hidden supplier dependencies 
  • Geographic and logistics concentration risks 
  • Supply disruptions impacting production timelines 
  • Increased costs from emergency procurement and expedited logistics
Risk identification was fragmented and reactive, making it difficult to anticipate disruptions or demonstrate risk management maturity to stakeholders, regulators, and customers.

Scope and Objectives

Goal: Improve multi-tier supply chain visibility, identify hidden risks, and enable proactive, data-driven sourcing and resiliency decisions.

Key Inputs

  • BOMs for four primary products and variants 
  • Tier 1 supplier data
  • Limited internal site and operational data
  • Previous supply chain assessments
 
Case Study

The Approach

 
1. Discover & Visualize
  • Ingested BOMs and supplier data to map tier 1 through tier 4 suppliers and dependencies
  • Inferred production geographies and supply flows across regulated components
  • Delivered a live, user-friendly, human-centric interactive canvas of the full value chain
pharma-cs-1
 
2. Identify Weak Spots
  • Identified geographic and commercial concentration risks
  • Uncovered previously unknown long-distance logistics dependencies
  • Detected inefficiencies and nearshoring reversals
  • Initiated continuous reputational risk monitoring across suppliers
pharma-cs-2-1
 
3. Mitigate
  • Surfaced alternative suppliers and diversification opportunities
  • Enabled nearshoring and dual-sourcing strategies
  • Provided enriched supplier intelligence for faster decision-making
pharma-cs-3
 
Outcomes
  • 100% validation accuracy at tier 2 supplier level
  • Identification of critical concentration and logistics risks
  • Detection of multiple geographic concentration risks across critical components
  • Reduction in time to insight from weeks to days
  • Identification of nearshoring reversals impacting cost and resilience
  • Strengthened ability to demonstrate risk maturity to boards and customers
 

Why Attaima?

  • Rapid deployment: Platform operational and delivering insights in days
  • Deep visibility: Extended beyond tier 1 to uncover hidden risks
  • Actionable intelligence: Enabled immediate sourcing and mitigation decisions
  • Continuous monitoring: Identified emerging risks in real time
  • Audit-ready outputs: Strengthened compliance and reporting

Next steps / ongoing work

  • Expand monitoring across all suppliers and product lines
  • Integrate advanced scenario modelling for proactive risk management
  • Extend insights to support long-term strategic sourcing decisions
med-tech-white
“ We uncovered risks we didn’t know existed and gained the ability to act before they impacted production and our customers. ”
— VP Operations
Medical Device Manufacturer

Emblem

Learn more about how Attaima can help your Medtech value chain